Companies: 10,795·Total market cap: $144.5T
QHSLab, Inc.

QHSLab, Inc.

USAQOTCHealthcare● Active
$0.35
+$0.10(+40.00%)
Market Cap$4297577
P/E Ratio—
52W High$1.136
52W Low$0.08
Cash on HandFinancialsRevenue

QHSLab, Inc. (USAQ) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

USAQ · cash on hand · updated Dec 31, 2025

Core cash position

Cash & Short-Term Investments (CCE + ST Investments)
$636,157▲ +304.8% vs prior year
FY · as of Dec 31, 2025 · Reported in USD
Cash & Cash Equiv. (CCE)
$636,157
cashAndCashEquivalents
Short-Term Investments
$0
shortTermInvestments
YoY Change vs Prior Year
+304.8%
vs prior fiscal year
Latest Quarter
$362,088
Q1 2026
Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2025

Net cash vs debt

Cash & ST Investments$636,157Cash on Hand
Total Debt$20,000Total Debt
Net Cash / Net Debt+$616,157Net Cash Position
Cash vs Debt Ratio
Cash 97%Debt 3%

QHSLab, Inc. has a net cash position of $616,157, holding more cash than debt.

Net Cash = Cash & ST Investments − Total Debt$636,157 − $20,000 = +$616,157

Cash on hand history

YoY Increase
YoY Decrease
Latest Year
USAQ annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

DateCash & ST InvestmentsYoY Change
Dec 31, 2025Latest$0.6M+304.8%
Dec 31, 2024$0.2M+204.7%
Dec 31, 2023$0.1M-71.1%
Dec 31, 2022$0.2M-37.7%
Dec 31, 2021$0.3M+204.1%
USAQ cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

#CompanyCash & ST Inv.Cash/MCap
#1
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$28.12B7.5%#2
Johnson & Johnson
Johnson & Johnson
JNJ
$20.10B3.5%#3
Eli Lilly and Company
Eli Lilly and Company
LLY
$7.27B0.7%#4
AbbVie Inc.
AbbVie Inc.
ABBV
$5.26B1.3%
#5
QHSLab, Inc.
QHSLab, Inc.YOU
USAQ
$0.6M14.8%
Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

QHSLab, Inc. (USAQ) cash on hand as of December 31, 2025 is $636,157, comprising $636,157 in cash and cash equivalents (CCE) plus $0 in short-term investments — reported as QHSLab, Inc. cash and short-term investments on the balance sheet (10-K filing). Also referred to as QHSLab, Inc. cash reserves or cash position.

QHSLab, Inc. annual cash on hand history shows increased +304.8% in 2025: increased +304.8% in 2025. QHSLab, Inc. cash reserves in 2025 reflect the company's capital allocation strategy.

QHSLab, Inc. carries total debt of $20,000 against cash of $636,157, resulting in a net cash position of +$616,157. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.
Financial statementsFree cash flowNet incomeRevenueMarket capP/E ratioEarningsPrice history

Frequently asked questions

USAQ cash on hand · 5 questions

As of December 31, 2025, QHSLab, Inc. (USAQ) has $636,157 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $636,157 in cash and cash equivalents (CCE) plus $0 in short-term investments. Latest quarter (March 31, 2026): $362,088. Data sourced from the annual 10-K filing via FMP.

USAQ cash on handUSAQ cash reservesUSAQ cash 2025how much cash does USAQ have

▸ Source: FMP /balance-sheet-statement · US GAAP · QHSLab, Inc. · QHSLab, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2025